130 related articles for article (PubMed ID: 15955737)
1. Identification of G-protein-coupled receptors involved in inflammatory disease by genetic association studies.
Pettipher R; Mangion J; Hunter MG; Mackay I
Curr Opin Pharmacol; 2005 Aug; 5(4):412-7. PubMed ID: 15955737
[TBL] [Abstract][Full Text] [Related]
2. Alternative drug discovery approaches for orphan GPCRs.
Levoye A; Jockers R
Drug Discov Today; 2008 Jan; 13(1-2):52-8. PubMed ID: 18190864
[TBL] [Abstract][Full Text] [Related]
3. Deorphanisation of G protein-coupled receptors: A tool to provide new insights in nervous system pathophysiology and new targets for psycho-active drugs.
Lecca D; Abbracchio MP
Neurochem Int; 2008 Feb; 52(3):339-51. PubMed ID: 17884255
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptors disrupted in human genetic disease.
Thompson MD; Percy ME; McIntyre Burnham W; Cole DE
Methods Mol Biol; 2008; 448():109-37. PubMed ID: 18370233
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptor pharmacogenetics.
Thompson MD; Siminovitch KA; Cole DE
Methods Mol Biol; 2008; 448():139-85. PubMed ID: 18370234
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
Thompson MD; Cole DE; Jose PA
Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. The future of G protein-coupled receptors as targets in drug discovery.
Lundstrom K
IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine.
Rosskopf D; Michel MC
Pharmacol Rev; 2008 Dec; 60(4):513-35. PubMed ID: 19074621
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptors as drug targets in inflammation and pain.
Vergnolle N
Pharmacol Ther; 2009 Sep; 123(3):292-309. PubMed ID: 19481569
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
Bond RA; Ijzerman AP
Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086
[TBL] [Abstract][Full Text] [Related]
12. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.
Soudijn W; Van Wijngaarden I; IJzerman AP
Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241
[TBL] [Abstract][Full Text] [Related]
14. Genomics in drug discovery: the best things come to those who wait.
Bansal AT; Barnes MR
Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
[TBL] [Abstract][Full Text] [Related]
15. Predicting ligands for orphan GPCRs.
Huang ES
Drug Discov Today; 2005 Jan; 10(1):69-73. PubMed ID: 15676301
[TBL] [Abstract][Full Text] [Related]
16. Marine sponge metabolites for the control of inflammatory diseases.
Alcaraz MJ; Payá M
Curr Opin Investig Drugs; 2006 Nov; 7(11):974-9. PubMed ID: 17117584
[TBL] [Abstract][Full Text] [Related]
17. The role of genetic association studies in identifying new drug targets.
Lowe JA; Jones P; Wilson DM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):603-5. PubMed ID: 18729011
[No Abstract] [Full Text] [Related]
18. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
19. Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.
Herrlinger KR; Jewell DP
Aliment Pharmacol Ther; 2006 Nov; 24(10):1403-12. PubMed ID: 17081161
[TBL] [Abstract][Full Text] [Related]
20. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes.
Takahashi N; Akahoshi M; Matsuda A; Ebe K; Inomata N; Obara K; Hirota T; Nakashima K; Shimizu M; Tamari M; Doi S; Miyatake A; Enomoto T; Nakashima H; Ikezawa Z; Shirakawa T
Hum Mol Genet; 2005 Nov; 14(21):3149-59. PubMed ID: 16159888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
